Aluminum compounds as vaccine adjuvants

被引:447
作者
Gupta, RK [1 ]
机构
[1] Wyeth Lederle Vaccines & Pediat, Pearl River, NY 10965 USA
关键词
alum; aluminum hydroxide; aluminum phosphate; adsorption; adjuvanticity;
D O I
10.1016/S0169-409X(98)00008-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aluminum compounds are the only adjuvants used widely with routine human vaccines and are the most common adjuvants in veterinary vaccines also. Though there has been a search for alternate adjuvants, aluminum adjuvants will continue to be used for many years due to their good track record of safety, low cost and adjuvanticity with a variety of antigens. For infections that can be prevented by induction of serum antibodies, aluminum adjuvants formulated under optimal conditions are the adjuvants of choice. It is important to select carefully the type of aluminum adjuvant and optimize the conditions of adsorption for every antigen since this process is dependent upon the physico-chemical characteristics of both the antigens and aluminum adjuvants. Adsorption of antigens onto aluminum compounds depends heavily on electrostatic forces between adjuvant and antigen. Two commonly used aluminum adjuvants, aluminum hydroxide and aluminum phosphate have opposite charge at a neutral pH. The mechanism of adjuvanticity of aluminum compounds includes formation of a depot; efficient uptake of aluminum adsorbed antigen particles by antigen presenting cells due their particulate nature and optimal size (< 10 mu m); and stimulation of immune competent cells of the body through activation of complement, induction of eosinophilia and activation of macrophages. Limitations of aluminum adjuvants include local reactions, augmentation of IgE antibody responses, ineffectiveness for some antigens and inability to augment cell-mediated immune responses, especially cytotoxic T-cell responses. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:155 / 172
页数:18
相关论文
共 167 条
[1]   Randomized controlled trial of acellular diphtheria, pertussis and tetanus vaccines in southern Ghana [J].
Afari, EA ;
Kamiya, Y ;
Nkrumah, FK ;
Dunyo, SK ;
Akpedonu, P ;
Kamiya, H ;
Fukai, F .
ANNALS OF TROPICAL PAEDIATRICS, 1996, 16 (01) :39-48
[2]   BOOSTER VACCINATION AGAINST DIPHTHERIA AND TETANUS IN MAN - COMPARISON OF CALCIUM-PHOSPHATE AND ALUMINUM HYDROXIDE AS ADJUVANTS .2. [J].
AGGERBECK, H ;
FENGER, C ;
HERON, I .
VACCINE, 1995, 13 (14) :1366-1374
[3]   ADJUVANTICITY OF ALUMINUM HYDROXIDE AND CALCIUM-PHOSPHATE IN DIPHTHERIA-TETANUS VACCINES .1. [J].
AGGERBECK, H ;
HERON, I .
VACCINE, 1995, 13 (14) :1360-1365
[4]  
AHUJA S, 1986, Indian Journal of Pathology and Microbiology, V29, P285
[5]   EFFECT OF PROTEIN ADSORPTION ON THE SURFACE-CHARGE CHARACTERISTICS OF ALUMINUM-CONTAINING ADJUVANTS [J].
ALSHAKHSHIR, R ;
REGNIER, F ;
WHITE, JL ;
HEM, SL .
VACCINE, 1994, 12 (05) :472-474
[6]   CONTRIBUTION OF ELECTROSTATIC AND HYDROPHOBIC INTERACTIONS TO THE ADSORPTION OF PROTEINS BY ALUMINUM-CONTAINING ADJUVANTS [J].
ALSHAKHSHIR, RH ;
REGNIER, FE ;
WHITE, JL ;
HEM, SL .
VACCINE, 1995, 13 (01) :41-44
[7]  
ALVING CR, 1993, ANN NY ACAD SCI, V690, P265
[8]   SUMMARY - ADJUVANTS CLINICAL-TRIALS WORKING GROUP [J].
ALVING, CR ;
GLASS, M ;
DETRICK, B .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (08) :1427-1430
[9]  
ANDRE FE, 1990, PROG MED VIROL, V37, P72
[10]  
[Anonymous], 1990, WHO TECH REP SER